World's Best Scientists 2026 revealed!
Clinical and Experimental Allergy
H-index 34

Clinical and Experimental Allergy

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 50 270 435 30
Medicine 679 207 286 29

Additional Metrics

Number of Best Scientists*: 502
Documents by Best Scientists*: 553
Top 100 Ranked Scientists*: 10
SCIMAGO H-index: 176
SCIMAGO SJR: 1.542
Impact Factor: 5.2

Overview

Top Research Topics at Clinical & Experimental Allergy?

The primary areas of discussion in the journal are Immunology, Allergy, Asthma, Immunoglobulin E and Allergen. The Immunology research presented places emphasis on topics like Atopy, Antibody, Immunopathology, Eosinophil and Antigen. Allergy research featured in Clinical & Experimental Allergy incorporates concerns from various other topics such as Atopic dermatitis, Provocation test and Sensitization.

The Asthma works featured in the journal incorporate elements from Respiratory disease, Epidemiology, Pediatrics and Disease. Issues in Immunoglobulin E were discussed, taking into consideration concepts from other disciplines like Epitope, Molecular biology, Immune system and Histamine. The research on Allergen featured in the journal combines topics in other fields like Pollen and Microbiology.

Gastroenterology, Placebo and Endocrinology are some topics wherein Internal medicine research discussed in it have an impact. Placebo research discussed connects with the study of Anesthesia.

  • Immunology (58.99%)
  • Allergy (34.99%)
  • Asthma (29.51%)

What are the most cited papers published in the journal?

  • Bronchial reactivity to inhaled histamine: a method and clinical survey. (1713 citations)
  • The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steering Committee. (1110 citations)
  • Probiotics in the management of atopic eczema. (879 citations)

Research areas of the most cited articles at Clinical & Experimental Allergy:

The journal publications mainly deal with areas of study such as Immunology, Allergy, Asthma, Immunoglobulin E and Allergen. The most cited publications facilitate discussions on Allergy that incorporate concepts from other fields like Internal medicine, Immunopathology and Atopic dermatitis. While Asthma is the focus of the published papers, it also provides insights into the studies of Odds ratio, Respiratory disease, Epidemiology, Pediatrics and Risk factor.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

The journal primarily focuses on research topics in Asthma, Immunology, Internal medicine, Allergy and Food allergy. Asthma research presented in Clinical & Experimental Allergy encompasses a variety of subjects, including Sputum, Disease, Atopic dermatitis, Airway and Cohort. Clinical & Experimental Allergy focuses on different Immunology studies like Immunoglobulin E, Allergen, Immune system, Inflammation and Sensitization.

It holds forums on Internal medicine that merges themes from other disciplines such as Gastroenterology and MEDLINE. Research in Coronavirus disease 2019 (COVID-19) and the interrelating topic of Virology were among the subjects of interest in the Allergy studies discussed in Clinical & Experimental Allergy. Clinical & Experimental Allergy focused on Food allergy research but expanded to cover Pediatrics.

The most cited articles from the last journal are:

  • Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine. (25 citations)
  • Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients. (22 citations)
  • Clinical evaluation of type 2 disease status in a real-world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical & Experimental Allergy (based on the number of publications) are:

  • Graham Roberts (83 papers) published 1 paper at the last edition, 12 less than at the previous edition,
  • Andrew J. Wardlaw (49 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • S. T. Holgate (49 papers) absent at the last edition,
  • Jean Bousquet (45 papers) published 1 paper at the last edition,
  • Rudolf Valenta (43 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical & Experimental Allergy (based on the number of publications) are:

  • Boston Children's Hospital (272 papers) published 29 papers at the last edition, 19 more than at the previous edition,
  • National Institutes of Health (256 papers) published 27 papers at the last edition, 18 more than at the previous edition,
  • University of Southampton (248 papers) published 12 papers at the last edition, 3 less than at the previous edition,
  • Southampton General Hospital (218 papers) absent at the last edition,
  • Karolinska Institutet (201 papers) published 12 papers at the last edition, 3 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.56% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 40.87% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.62% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.58% of all publications and 38.94% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Mechanisms of Dupilumab

    Hani Harb;Talal A. Chatila

    (2020)
    439 Citations
  • Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.

    Priya Sellaturay;Shuaib Nasser;Sabita Islam;Padmalal Gurugama

    (2021)
    243 Citations
  • Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19

    Daniel Munblit;Daniel Munblit;Polina Bobkova;Ekaterina Spiridonova;Anastasia Shikhaleva

    (2021)
    193 Citations
  • Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.

    Jennifer D Hamilton;Sivan Harel;Brian N Swanson;William Brian

    (2021)
    116 Citations
  • Anxiety and food allergy: A review of the last two decades

    Laura Polloni;Antonella Muraro

    (2020)
    86 Citations
  • Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis

    (2022)
    75 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their healthcare expertise beyond traditional medical school, pursuing an online nursing PhD programs offers an affordable and flexible path. These programs prepare candidates for advanced clinical roles, leadership, and research opportunities in nursing.

Another vital area in healthcare is medical billing and coding. Earning a medical coding and billing certification can open doors to specialized administrative roles that support the medical system. It is a well-recognized credential that enhances employability and offers financial aid options for learners.

For students with a biology background, numerous career options exist beyond medicine. Exploring biology major careers reveals opportunities in research, biotechnology, environmental sciences, and healthcare allied fields, many of which provide competitive salaries.

Additionally, healthcare professionals interested in medical coding can advance their qualifications by obtaining the ccs certification. This certification offers higher salary prospects and recognizes expertise in clinical coding, a crucial component of healthcare administration.

Best Scientists Contributing to This Journal

Recently Published Articles